BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 19179668)

  • 1. Autophagy in ischemic heart disease.
    Gustafsson AB; Gottlieb RA
    Circ Res; 2009 Jan; 104(2):150-8. PubMed ID: 19179668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.
    Ananthakrishnan R; Kaneko M; Hwang YC; Quadri N; Gomez T; Li Q; Caspersen C; Ramasamy R
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H333-41. PubMed ID: 19060123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of Bcl-2 sensitizes mitochondrial permeability transition pore (MPTP) opening in ischemia-damaged mitochondria.
    Chen Q; Xu H; Xu A; Ross T; Bowler E; Hu Y; Lesnefsky EJ
    PLoS One; 2015; 10(3):e0118834. PubMed ID: 25756500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recycle or die: the role of autophagy in cardioprotection.
    Gustafsson AB; Gottlieb RA
    J Mol Cell Cardiol; 2008 Apr; 44(4):654-61. PubMed ID: 18353358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orientin-induced cardioprotection against reperfusion is associated with attenuation of mitochondrial permeability transition.
    Lu N; Sun Y; Zheng X
    Planta Med; 2011 Jul; 77(10):984-91. PubMed ID: 21283956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial PKC-ε deficiency promotes I/R-mediated myocardial injury via GSK3β-dependent mitochondrial permeability transition pore opening.
    Wang S; Zhang F; Zhao G; Cheng Y; Wu T; Wu B; Zhang YE
    J Cell Mol Med; 2017 Sep; 21(9):2009-2021. PubMed ID: 28266127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New roles for mitochondria in cell death in the reperfused myocardium.
    Ong SB; Gustafsson AB
    Cardiovasc Res; 2012 May; 94(2):190-6. PubMed ID: 22108916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal mitochondrial function during ischemia reperfusion provides targets for pharmacological therapy.
    García-Rivas GJ; Torre-Amione G
    Methodist Debakey Cardiovasc J; 2009; 5(3):2-7. PubMed ID: 20308957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria "THE" target of myocardial conditioning.
    Boengler K; Lochnit G; Schulz R
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1215-H1231. PubMed ID: 30004243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia.
    Shohet RV; Garcia JA
    J Mol Med (Berl); 2007 Dec; 85(12):1309-15. PubMed ID: 18026917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive thermopreconditioning attenuates rat cardiac ischemia/reperfusion injury by mitochondria-mediated antioxidant and antiapoptotic mechanisms.
    Chien CY; Chien CT; Wang SS
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):705-13. PubMed ID: 24507988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.
    Bhamra GS; Hausenloy DJ; Davidson SM; Carr RD; Paiva M; Wynne AM; Mocanu MM; Yellon DM
    Basic Res Cardiol; 2008 May; 103(3):274-84. PubMed ID: 18080084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease.
    Cadenas S; Aragonés J; Landázuri MO
    Cardiovasc Res; 2010 Nov; 88(2):219-28. PubMed ID: 20679415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
    Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaempferol protects cardiomyocytes against anoxia/reoxygenation injury via mitochondrial pathway mediated by SIRT1.
    Guo Z; Liao Z; Huang L; Liu D; Yin D; He M
    Eur J Pharmacol; 2015 Aug; 761():245-53. PubMed ID: 26086862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole.
    Di Lisa F; Bernardi P
    Cardiovasc Res; 2006 May; 70(2):191-9. PubMed ID: 16497286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered FoF1 ATP synthase and susceptibility to mitochondrial permeability transition pore during ischaemia and reperfusion in aging cardiomyocytes.
    Fernandez-Sanz C; Ruiz-Meana M; Castellano J; Miro-Casas E; Nuñez E; Inserte J; Vázquez J; Garcia-Dorado D
    Thromb Haemost; 2015 Mar; 113(3):441-51. PubMed ID: 25631625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone Ameliorates Myocardial Ischemia/Reperfusion Injury in Rat by Inhibiting Apoptosis and Autophagy Via the PI3K-Akt Signal Pathway.
    Xuan F; Jian J; Lin X; Huang J; Jiao Y; Huang W; Li J; Shi Z; Huang R
    Cardiovasc Toxicol; 2017 Jan; 17(1):79-87. PubMed ID: 26792585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
    Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
    Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fatty acids in isolated mitochondria: implications for ischemic injury and cardioprotection.
    Korge P; Honda HM; Weiss JN
    Am J Physiol Heart Circ Physiol; 2003 Jul; 285(1):H259-69. PubMed ID: 12793979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.